Arvinas, Inc. (ARVN)
9.09
-0.01
(-0.11%)
USD |
NASDAQ |
May 22, 16:00
9.09
0.00 (0.00%)
After-Hours: 20:00
Arvinas Cash from Investing (Quarterly) : 13.70M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | 785.00M |
| Rigel Pharmaceuticals, Inc. | -7.975M |
| EyePoint, Inc. | 59.05M |
| Elanco Animal Health, Inc. | -60.00M |
| Corcept Therapeutics, Inc. | 4.542M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -69.20M |
| Cash from Financing (Quarterly) | -0.10M |
| Free Cash Flow | -256.90M |
| Free Cash Flow Per Share (Quarterly) | -1.102 |
| Free Cash Flow to Equity (Quarterly) | -70.00M |
| Free Cash Flow to Firm (Quarterly) | -70.50M |
| Free Cash Flow Yield | -41.09% |